ITGB1 and neoplasm: The results showed that NSCLC patients with high ITGB1 expression and low miR-493-5p levels had significantly decreased OS (P < 0.001) (Figure 5G), which suggested that ITGB1 and miR-493-5p might have potential prognostic value and could be useful as tumor biomarkers for the diagnosis of NSCLC patients.